BioSpace News Archive

Kynos Therapeutics Emerges from Stealth with £9 Million Financing and Phase 1-ready KMO Inhibitor

Kynos is a spin-out from the University of Edinburgh (UoE), based on over a decade of research into KMO biology and its inhibitors.

April 7, 2022
·
6 min read
Renowned Immunotherapy Expert Dr. Michael Kalos joins Anocca’s Scientific Advisory Board

Anocca, a biotechnology company using its precision biology platforms to engineer a broad portfolio of innovative T cell therapeutics, today announced the appointment of Dr. Michael Kalos to its Scientific Advisory Board (SAB).

April 7, 2022
·
3 min read
Henlius’ Serplulimab Granted Orphan-Drug Designation in the United States for Small Cell Lung Cancer

Shanghai Henlius Biotech, Inc. announced that the United States Food and Drug Administration has granted Orphan-Drug Designation for HANSIZHUANG for the treatment of small cell lung cancer.

April 7, 2022
·
7 min read
SeekIn Receives CE Mark Approval for LeukoPrint® Molecular Karyotyping Test

SeekIn Inc, the leader in blood-based cancer early detection and monitoring technology, today announced the CE (Conformité Européenne) Mark for LeukoPrint® Molecular Karyotyping Kit and is now ready to launch this test in European markets.

April 7, 2022
·
3 min read
Genetown

Correction: Zealand Pharma major shareholder announcement: Polar Capital LLP, April 7 2022

Zealand Pharma A/S announces the receipt of notification pursuant to Section 38 of the Danish Capital Markets Act from the following major shareholders:

April 7, 2022
·
2 min read
Defence Therapeutics Announces Issuance Of a U.S. Patent Covering Its Pioneering Vaccine Platform Technology

The ‘717 patent provides broad protection for Defence’s extremely versatile vaccine platform that can be incorporated into virtually any cell-based or protein subunit vaccine to enhance immunogenicity.

April 7, 2022
·
3 min read
Biotech Beach

Viracta Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference

Viracta Therapeutics, Inc. announced that company leadership is scheduled to present at the 21st Annual Needham Virtual Healthcare Conference, on Wednesday, April 13, 2022, at 3:00 p.m. EDT.

April 7, 2022
·
1 min read
ESSENT BIOLOGICS LAUNCHES WHARTON’S JELLY-DERIVED HUMAN MESENCHYMAL STROMAL CELLS TO FURTHER CELL THERAPY RESEARCH

Essent Biologics™, a leading supplier of adult human-derived cell and scaffold materials, today announced it has launched a new line of primary cells: Wharton’s jelly-derived Mesenchymal Stromal Cells (hWJMSC), to its growing product portfolio.

April 7, 2022
·
2 min read
Cardiac Catheters Market Analysis, Statistics, Revenue, Demand and Trend Analysis Research Report by 2027

The industry analysis report is considered a valuable source of information about the global Cardiac Catheters industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

April 7, 2022
·
7 min read
Drug Development

Stoke Therapeutics to Present at The Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual Meeting

Stoke Therapeutics, Inc. announced today the upcoming presentation of new preclinical data on STK-002 at The Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual Meeting being held May 1-4, 2022 in Denver, Colorado.

April 7, 2022
·
4 min read